0

BMS-189453

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP166977431
CAS166977-43-1
MDL NumberMFCD18086870
Molecular Weight380.48
InChI KeyVUODRPPTYLBGFM-CMDGGOBGSA-N
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

BMS-189453, a Novel Retinoid Receptor Antagonist, Is a Potent Testicular Toxin

G E Schulze, R J Clay, L E Mezza, C L Bregman, R A Buroker, J D Frantz

Toxicol Sci. 2001 Feb;59(2):297-308.

PMID: 11158723

1

Brdt Bromodomains Inhibitors and Other Modern Means of Male Contraception

Zygmunt Zdrojewicz, Radosław Konieczny, Paulina Papier, Filip Szten

Adv Clin Exp Med. Jul-Aug 2015;24(4):705-14.

PMID: 26469117

1

Congenital Diaphragmatic Hernia After Exposure to a Triple Retinoic Acid Antagonist During Pregnancy

Daria Cipollone, Denis A Cozzi, Rita Businaro, Bruno Marino

J Cardiovasc Med (Hagerstown). 2017 May;18(5):389-392.

PMID: 21107276

1

Inhibition of Disease Progression by a Novel Retinoid Antagonist in Animal Models of Arthritis

Blake C Beehler, Yong-Jiang Hei, Simon Chen, John A Lupisella, Jacek Ostrowski, John E Starrett, David Tortolani, Kenneth M Tramposch, Peter R Reczek

J Rheumatol. 2003 Feb;30(2):355-63.

PMID: 12563696

1

New Approaches to Male Non-Hormonal Contraception

Jean-Jacques Nya-Ngatchou, John K Amory

Contraception. 2013 Mar;87(3):296-9.

PMID: 22995542

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode